Showing results (161-170 of 239) with videos related to
Sort By:
Pageof 24
European Urology Oncology|May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell CarcinomaMichael A Gorin, Hiten D Patel, Steven P Rowe, et al.The Journal of Clinical Investigation|January 17, 2018
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regressionHaidong Tang, Yong Liang, Robert A Anders, et al.The American Journal of Surgical Pathology|August 18, 2017
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic PatternGenevieve J Kaunitz, Manisha Loss, Hira Rizvi, et al.Journal for Immunotherapy of Cancer|June 20, 2020
Chronic immune checkpoint inhibitor pneumonitisJarushka Naidoo, Tricia R Cottrell, Evan J Lipson, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 21, 2024
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short versionChristos C Zouboulis, Falk G Bechara, Klaus Fritz, et al.Journal of Internal Medicine|December 28, 2017
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liverP Dongiovanni, S Stender, A Pietrelli, et al.Journal for Immunotherapy of Cancer|June 4, 2021
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trialRobert L Ferris, William C Spanos, Rom Leidner, et al.Cancer Immunology Research|August 26, 2021
Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker DiscoveryNicolas A Giraldo, Sneha Berry, Etienne Becht, et al.Cancer Immunology Research|January 20, 2019
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell FunctionSarah Whelan, Eran Ophir, Maya F Kotturi, et al.Cancer Discovery|November 1, 2014
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpointsNicolas J Llosa, Michael Cruise, Ada Tam, et al.Pageof 24